Literature DB >> 33311651

MRI-guided active surveillance in prostate cancer: not yet ready for practice.

Guillaume Ploussard1, Raphaële Renard-Penna2.   

Abstract

Entities:  

Year:  2020        PMID： 33311651     DOI： 10.1038/s41585-020-00416-2

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  2 in total

1.  Multiparametric magnetic resonance imaging facilitates reclassification during active surveillance for prostate cancer.

Authors:  Atsuko Fujihara; Tsuyoshi Iwata; Aliasger Shakir; Alessandro Tafuri; Giovanni E Cacciamani; Karanvir Gill; Akbar Ashrafi; Osamu Ukimura; Mihir Desai; Vinay Duddalwar; Mariana S Stern; Manju Aron; Suzanne L Palmer; Inderbir S Gill; Andre Luis Abreu
Journal:  BJU Int       Date:  2020-12-10       Impact factor: 5.588

2.  Natural history of prostate cancer on active surveillance: stratification by MRI using the PRECISE recommendations in a UK cohort.

Authors:  Francesco Giganti; Armando Stabile; Vasilis Stavrinides; Elizabeth Osinibi; Adam Retter; Clément Orczyk; Valeria Panebianco; Bruce J Trock; Alex Freeman; Aiman Haider; Shonit Punwani; Clare Allen; Alex Kirkham; Mark Emberton; Caroline M Moore
Journal:  Eur Radiol       Date:  2020-09-30       Impact factor: 5.315
  2 in total
  4 in total

1.  Comparison of diagnostic performance and inter-reader agreement between PI-RADS v2.1 and PI-RADS v2: systematic review and meta-analysis.

Authors:  Chau Hung Lee; Balamurugan Vellayappan; Cher Heng Tan
Journal:  Br J Radiol       Date:  2021-09-14       Impact factor: 3.039

2.  Serial changes in tumour measurements and apparent diffusion coefficients in prostate cancer patients on active surveillance with and without histopathological progression.

Authors:  Nikita Sushentsev; Iztok Caglic; Leonardo Rundo; Vasily Kozlov; Evis Sala; Vincent J Gnanapragasam; Tristan Barrett
Journal:  Br J Radiol       Date:  2021-09-19       Impact factor: 3.039

3.  Unified model involving genomics, magnetic resonance imaging and prostate-specific antigen density outperforms individual co-variables at predicting biopsy upgrading in patients on active surveillance for low risk prostate cancer.

Authors:  Alp Tuna Beksac; Parita Ratnani; Zachary Dovey; Sneha Parekh; Ugo Falagario; Reza Roshandel; Stanislaw Sobotka; Deepshikha Kewlani; Avery Davis; Rachel Weil; Hafis Bashorun; Ivan Jambor; Sara Lewis; Kenneth Haines; Ashutosh K Tewari
Journal:  Cancer Rep (Hoboken)       Date:  2021-12-20

4.  Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium database.

Authors:  Kerri R Beckmann; Chris H Bangma; Jozien Helleman; Anders Bjartell; Peter R Carroll; Todd Morgan; Daan Nieboer; Aida Santaolalla; Bruce J Trock; Riccardo Valdagni; Monique J Roobol
Journal:  Prostate       Date:  2022-03-07       Impact factor: 4.012
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.